Brief: Enveric Biosciences Receives Notice Of Allowance From Uspto For Novel Prodrug Of Psilocin
18/05/2023 13:08
Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES RECEIVES NOTICE OF ALLOWANCE FROM
USPTO FOR
NOVEL PRODRUG OF PSILOCIN
* ENVERIC BIOSCIENCES INC - HAS FILED FURTHER COMPOSITION OF
MATTER PATENT APPLICATIONS WITH USPTO FOR PSILOCIN PRODRUGS
Source text for Eikon: ID:nBwbtLDtMa
Further company coverage: ENVB.O
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003